LOWELL GEORGE enters SCINAI IMMUNOTHERAPEUTICS LTD. with 421.68K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 1/3/2023ACC: 0001213900-23-000334
Director
Since Jan 2023
421.68K
Baseline shares
100% direct
421.68K
Direct ownership
1 position
1.85M
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares
DirectShares owned421.68K
Total
421.68K direct421.68K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 421.68K | Direct |
| Total | 421.68K | 421.68K direct |
Derivative Holdings3
Restricted Share Units
DirectUnderlying security
Ordinary Shares
Underlying shares
133.20K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Stock Options (right to buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
720K
Shares owned
N/A
Exercise price
0.199
Expiration
—
Exercise window
—
Stock Options (right to buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
1M
Shares owned
N/A
Exercise price
1.738
Expiration
—
Exercise window
—
Total
Underlying
1.85M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Restricted Share Units Direct | Ordinary Shares | — | — | 133.20K | N/A | |
| Stock Options (right to buy) Direct | Ordinary Shares | 0.199 | — | — | 720K | N/A |
| Stock Options (right to buy) Direct | Ordinary Shares | 1.738 | — | — | 1M | N/A |
| Total | 1.85M | 0.00 | ||||